MedTrace Logo

The Collection and Application of Autologous Amniotic Fluid At Cesarean Delivery Closure.

NCT04359472 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-12-13

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility of collecting amniotic fluid at delivery that will be immediately processed and then applied as a spray to the various layers of cesarean wound closure.

Conditions

  • Pregnancy Related
  • Cesarean Wound Disruption
  • Cesarean Section; Infection

Interventions

DEVICE

Application of Autologous Amniotic Fluid

Collection and reapplication of amniotic fluid at wound layers during a cesarean section.

Sponsors & Collaborators

Principal Investigators

  • Jennifer Gilner, MD · Duke University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2023-09-01
Completion
2024-09-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04359472 on ClinicalTrials.gov